Use of acetylsalicylic acid (ASA) in the application of a membrane lung
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 1, 2007
app pub date -
Apr 19, 2007
filing date -
Apr 21, 2006
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Acetylsalicylic acid (ASA) is used as a medicament which is administered to a human patient in connection with a treatment of the patient with a membrane lung, in order to avoid or reduce a deposition of blood constituents in the membrane lung. The administration of the medicament involves ASA initially being administered once, several times or continuously each day in a therapeutically effective daily amount that lies below the risk range for analgesic efficacy of ASA.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully